CRP and major depressive disorder: To identify transcriptomic profiles that cut across CRP and treatment-based groups while limiting the number of subgroup analyses, we grouped patients in current MDD (non-responders and unmedicated), and remitted MDD (responders), and further divided them based on levels of CRP in >1 or <1 mg/L.